Search

Your search keyword '"Su, Ying-Ying"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Su, Ying-Ying" Remove constraint Author: "Su, Ying-Ying"
305 results on '"Su, Ying-Ying"'

Search Results

1. Fusion of Diffusion Weighted MRI and Clinical Data for Predicting Functional Outcome after Acute Ischemic Stroke with Deep Contrastive Learning

2. Venovenous extracorporeal membrane oxygenation (VV-ECMO) for severe acute respiratory distress syndrome (ARDS) in adults—a single-center experience

4. Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial

6. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

7. Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

10. Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial

11. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

12. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

20. Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women

24. A five-compartment model of age-specific transmissibility of SARS-CoV-2

29. The efficacy and safety of an intranasal spray COVID-19 vaccine in a randomized double-blind placebo-controlled phase Ⅲ trial during Omicron period

33. Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis

37. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial

41. Additional file 1 of Risk of hepatocellular carcinoma in antiviral treatment-na��ve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

43. Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis.

44. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

49. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project

50. Neutralizing and binding antibody kinetics of COVID-19 patients during hospital and convalescent phases

Catalog

Books, media, physical & digital resources